SCHEMBL12503595

SCHEMBL12503595

C[Si](C)(C)CCOCN(COCC[Si](C)(C)C)c1cc(C2CC3CCC(C2)N3C(=O)O)nc2c(-c3ccc(-c4ccccc4F)nc3)cnn12

nearest known ligand 0.38

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
MTOR P42345 5/20 0.38
RPTOR Q8N122 5/20 0.38
MLST8 Q9BVC4 5/20 0.38
DGAT1 O75907 4/20 0.34
ALOX5AP P20292 4/20 0.33
FEN1 P39748 4/20 0.33
FFAR2 O15552 1/20 0.32
DHODH Q02127 1/20 0.31
CHEK1 O14757 1/20 0.31
CCNA2 P20248 1/20 0.31
CDK2 P24941 1/20 0.31
CCNA1 P78396 1/20 0.31
CYP3A4 P08684 1/20 0.31
TTK P33981 1/20 0.31
LTB4R Q15722 1/20 0.30
WNT3A P56704 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12503601 0.94 MTOR (0.37) MTORRPTORMLST8DGAT1
SCHEMBL2732777 0.92 MTOR (0.45) MTORRPTORMLST8DGAT1CHEK1
SCHEMBL15007356 0.91 MTOR (0.35) MTORRPTORMLST8DGAT1ALOX5AP
SCHEMBL15026274 0.89 ALOX5AP (0.35) MTORRPTORMLST8DGAT1ALOX5AP
SCHEMBL2147143 0.88 MTOR (0.35) MTORRPTORMLST8DGAT1
SCHEMBL10238471 0.88 ALOX5AP (0.36) DGAT1ALOX5APFEN1CHEK1CCNA2
SCHEMBL12503597 0.87 MTOR (0.39) MTORRPTORMLST8DGAT1CHEK1
SCHEMBL2706919 0.87 MTOR (0.35) MTORRPTORMLST8DGAT1
SCHEMBL2147472 0.85 MTOR (0.34) MTORRPTORMLST8
SCHEMBL12460795 0.85 MTOR (0.34) MTORRPTORMLST8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2608668-A1 FUSED TRICYCLIC INHIBITORS OF MAMMALIAN TARGET OF RAPAMYCIN Merck Sharp & Dohme Corp. (US) 2013-07-03 EP disclosed
WO-2012027234-A1 FUSED TRICYCLIC INHIBITORS OF MAMMALIAN TARGET OF RAPAMYCIN SCHERING CORPORATION (US) 2012-03-01 WO disclosed